---
title: "Tetrapharm Bioengineering ApS — Datapublica Risk Score (CVR 46672909) | Datapublica"
description: "Tetrapharm Bioengineering ApS (CVR 46672909): Our statistical assessment of the risk of future financial problems that could affect the company’s ability to pay. A lower score is better; a higher score indicates stronger signs of financial distress."
canonical_url: "https://datapublica.dk/en/companies/46672909-tetrapharm-bioengineering-aps/risk"
locale: "en"
route_type: "company_risk"
robots: "index,follow"
content_access: "standard"
---

# Tetrapharm Bioengineering ApS — Risk

Tetrapharm Bioengineering ApS \(CVR 46672909\): Our statistical assessment of the risk of future financial problems that could affect the company’s ability to pay. A lower score is better; a higher score indicates stronger signs of financial distress.

CVR 46672909

## Financial distress score

- **Risk Score:** 100 / 100

- **Risk band:** Elevated risk

- **National percentile:** 90.6

- **Updated:** 27 Sept 2026

The model finds several signals associated with future financial distress in the available data.

### Main drivers

- Management and board track record • -8 • Lowers the score

- Company age • +48 • Raises the score

- Management and board composition • +11 • Raises the score
